The Ophthalmic Oncology Task Force, including doctors from The New York Eye Cancer Center, just published the results of one of the largest multi-center, international studies of eye cancer in history. Their findings were published in Ophthalmology, the most widely read journal in the discipline, from the American Academy of Ophthalmology. This study has shown [..] Read More…
The New York Eye Cancer Center is thrilled to announce it is the first clinic in the United States to use the state-of-art OCT2 imaging machine from Heidelberg Engineering. The machine was publicly released earlier this year and installed at NYECC the week before Christmas. It reflects Dr. Finger’s continuing commitment to provide cutting-edge, next-generation eye cancer care. Dr. Finger [..] Read More…
Dr. Paul Finger of the New York Eye Cancer Center is honored to be the sole author of all eye cancer sections in the latest edition of the Manual of Clinical Oncology. Published last September, the Manual is an essential reference text for clinicians treating and caring for oncology patients anywhere on the globe. The [..] Read More…
New York Eye Cancer Center Director Dr. Paul T. Finger has practiced medicine for over 30 years, but that doesn’t mean we’re set in our ways. Research into eye cancer is moving at breakneck speed, and the NYECC is always working to set the curve. We’re proud to announce the completion of two projects to [..] Read More…
Dr. Paul Finger has been named one of the top cancer doctors of 2015 in the United States by Newsweek. The magazine compiles its annual list through peer nominations and extensive research conducted by Castle Connolly Medical LTD: “The Castle Connolly physician-led research team makes tens of thousands of phone calls each year, talking with [..] Read More…
Dr. Finger’s latest research, co-authored with Kimberly J. Chin and Ekaterina A. Semenova, was published in the European Journal of Ophthalmology. It was made available in PDF and EPUB eBook formats earlier this year. Download it below. Download a PDF of This Study Here is the opening summary of this research article titled, Intravitreal Anti-VEGF Therapy For Macular [..] Read More…
Through his extensive research, Dr. Finger has shown that not all radiation techniques for treating eye cancer are equal. Though all radiation treatments kill cancer cells, there are significant dose-related differences in the severity and distribution of side effects depending on the technique. For example, as early as 1990, Dr. Finger’s research showed that compared [..] Read More…
Although ocular melanoma can spread to other parts of the body, it is important to know that most patients do not develop metastases. However, because there is a risk, we highly recommend initial and follow up systemic evaluations. At The New York Eye Cancer Center, we suggest patients have a complete physical examination at the [..] Read More…
Choroidal melanoma is the most common eye cancer in adults, and Dr. Finger’s research has been key to developing treatments. Download the PDF Here Even so, it is still extremely rare. Annually, 4-6 people per million in the US are diagnosed with choroidal melanoma, and it is found in 10-12 people per million in Australia, [..] Read More…
Dr. Finger’s research of conjunctiva tumors leads to three important points. The first surgery offers the best chance for a cure. Larger tumors require more complex multi-modality treatments. Eyes and vision can be salvaged through the use of radiation.
"Very well treated by Dr. Finger. He explained everything I needed to know about my issue with detail and attention, putting me at ease and giving me confidence to handle this problem for the rest of my life.”
– N.N.
